NCT07166549 : Clinical Trial Detail - Cancer Knowledgebase (CKB)

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT07166549
Title	Bispecific CAR T Cells for B-cell Malignancies (BaseCAR-01 Trial) (BaseCAR-01)
Acronym	BaseCAR-01
Recruitment	Not yet recruiting
Gender	both
Phase	Phase I
Variant Requirements	No
Sponsors	University Hospital, Basel, Switzerland
Indications	hairy cell leukemia B-cell acute lymphoblastic leukemia marginal zone lymphoma B-cell lymphoma central nervous system lymphoma lymphoplasmacytic lymphoma Burkitt lymphoma high-grade B-cell lymphoma double-hit/triple-hit primary mediastinal B-cell lymphoma chronic lymphocytic leukemia/small lymphocytic lymphoma mantle cell lymphoma diffuse large B-cell lymphoma follicular lymphoma
Therapies	Anti-CD19-CD20 CAR T cells
Age Groups:	senior \| adult
Covered Countries	CHE

Facility	Status	City	State	Zip	Country	Details
University Hospital Basel, Division of Hematology or Medical Oncology		Basel	Canton of Basel-City	4031	Switzerland	Details

*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field

NCT07166549Clinical Trial Detail